Cancer BiologybioRxivPreprint
ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinoma
Sarah Laing, Björn Kruspig, Robin Shaw…·Daniel J. Murphy
The paper investigates how ERBB signaling contributes to immune evasion in KRAS-driven lung adenocarcinoma using a novel mouse model and finds that transient ERBB blockade can restore immune surveillance when combined with PD1 blockade.
1 citation